Additionally, anemia (11 of 46, 23.9%), thrombocytopenia (11 of 46, 23.9%), leukopenia (8 of 46, 17.4%), neutropenia (7 of 46, 15.2%), alanine aminotransferase (ALT) elevation (6 of 46, 13.0%), and AST elevation (6 of 46, 13.0%) were also common among these patients. This evidence concerns the gene GPT and neutropenia.